Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
FTC
FTC Seeks Comments on the Impact of Pharmacy Benefit Managers’ Practices
Earlier this year, the Federal Trade Commission (FTC) issued a Request for Information, covering a wide range of topics in the…
DOJ and FTC Aim to Increase Merger Enforcement
In January 2022, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) Antitrust Division announced a joint…
FTC Announces $40 Million Settlement with Vyera Pharmaceuticals
In early December 2021, the United States Federal Trade Commission (FTC), along with several state co-plaintiffs (New York,…
FTC Releases Report on Rebate Walls, Vows to Promote Competition in…
Earlier this year, the United States Federal Trade Commission (FTC) released its “Report on Rebate Walls” to Congress, which gave…
FTC to Review Approach to Mergers and Acquisitions
In March 2021, the Federal Trade Commission (FTC) announced a review of its approach to biopharmaceutical mergers and…
Fifth Circuit Upholds FTC Ruling on Impax Antitrust Violations
On April 13, 2021, the United States Court of Appeals for the Fifth Circuit denied a Petition for Review filed by Impax…
FTC to Examine Impact of Hospital Acquisitions of Physician Practices on…
Earlier this year, the United States Federal Trade Commission (FTC) sent orders to six health insurance companies, seeking data on…
Court of Appeals Overturns $448 Million Disgorgement Against AbbVie,…
On September 30, 2020, the United States Court of Appeals for the Third Circuit voided a $448 million award by the United States…
Federal Trade Commission Asks CMS to Reduce Reimbursement Requirements for…
Recently, the Federal Trade Commission (FTC) submitted a comment to the Centers for Medicare & Medicaid Services (CMS) in…
Federal Trade Commission (FTC) Annual Report: Sets Their Sites on Life…
The Federal Trade Commission (“FTC”) recently released its annual report for 2019. The FTC’s annual report details the FTC’s…